Learn More
Chemie Tek RMC-6291 covalent inhibitor 5mg

Supplier: Chemie Tek CTRMC629110MG
RMC-6291 is an orally bioavailable, covalent inhibitor of the active, guanosine triphosphate (GTP)-bound form of the oncogenic KRAS substitution mutation G12C, KRASG12C(ON). RMC-6291 forms a tri-complex with the intracellular chaperone protein and immunophilin cyclophilin A (CypA) and KRASG12C(ON). This tri-complex blocks KRASG12C(ON)-mediated signaling. RMC-6291 elicits deep and durable suppression on RAS pathway activity in KRASG12C tumor models (refs 1, 2).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.